Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted for review GSK's new drug application (NDA) for Blenrep ...

Japan’s MHLW accepts for review GSK’s NDA for Blenrep combinations in relapsed/refractory multiple myeloma: London, UK Wednesday, September 18, 2024, 10:00 Hrs [IST] GSK plc a ...

King of Prussia, Pennsylvania Monday, September 16, 2024, 17:00 Hrs [IST] ...

Drug maker GSK plc (GSK, GSK.L) announced Tuesday that Blenrep (belantamab mafodotin) combinations in relapsed/refractory multiple ...

Osaka Metropolitan University researchers analyzed the incidence in Japan of COVID-19-associated pulmonary aspergillosis ...

In the past 60 days, the Zacks Consensus Estimate for Arcturus’ 2024 loss per share has narrowed from $4.39 to $2.60. Also, the Zacks Consensus Estimate for 2025 has moved from a loss of 45 cents to ...

Investigating Japanese longevity reveals the impact of lifestyle medicine and government strategies on health, offering ...

CSL and self-amplifying mRNA (sa-mRNA) pioneer Arcturus Therapeutics today announced that Japan's Ministry of Health, Labor and Welfare (MHLW) granted approval and authorization for their updated ...

Canaccord Genuity analyst Whitney Ijem maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) yesterday and set a ...

Cheryl Hines is reportedly fuming over her husband Robert F Kennedy Jr's alleged sexting scandal with reporter Olivia Nuzzi, which began during his presidential campaign. New York Magazine placed ...

Sunday's matchup in New Orleans could serve as a confidence-infusing springboard for the Eagles defense -- or, it could deepen doubts. Philadelphia Phillies (92-62, first in the NL East) vs. New ...

Aug. 21, 2024 — Lithium iron phosphate is one of the most important materials for batteries in electric cars, stationary energy storage systems and tools. It has a long service life, is ...